TORRENT PHARMACEUTICALS
Back to Balance Sheet
|
TORRENT PHARMACEUTICALS Last 5 Year Capital Work in Progress History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Capital Work in Progress | ₹457 Cr | ₹367 Cr | ₹281 Cr | ₹688 Cr | ₹544 Cr |
What is the latest Capital Work in Progress ratio of TORRENT PHARMACEUTICALS ?
| Year | Capital Work in Progress |
|---|---|
| Mar2026 | ₹457 Cr |
| Mar2025 | ₹367 Cr |
| Mar2024 | ₹281 Cr |
| Mar2023 | ₹688 Cr |
| Mar2022 | ₹544 Cr |
How is Capital Work in Progress of TORRENT PHARMACEUTICALS Trending?
| Years | Capital Work in Progress | % Change | |
|---|---|---|---|
| Mar2026 | ₹457 Cr | 24.57 | |
| Mar2025 | ₹367 Cr | 30.79 | |
| Mar2024 | ₹281 Cr | -59.20 | |
| Mar2023 | ₹688 Cr | 26.44 | |
| Mar2022 | ₹544 Cr | - | |
Compare Capital Work in Progress of peers of TORRENT PHARMACEUTICALS
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| TORRENT PHARMACEUTICALS | ₹185,232.0 Cr | -2.4% | -3.1% | 36.4% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹441,478.0 Cr | -0.2% | -3.2% | 12.7% | Stock Analytics | |
| DIVIS LABORATORIES | ₹253,031.0 Cr | 2% | 5.3% | 57.7% | Stock Analytics | |
| CIPLA | ₹112,205.0 Cr | 0.6% | -2.2% | -9.4% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹102,040.0 Cr | 0.9% | 4% | -7.6% | Stock Analytics | |
| MANKIND PHARMA | ₹100,764.0 Cr | -1.6% | 0.9% | -4.7% | Stock Analytics | |
TORRENT PHARMACEUTICALS Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| TORRENT PHARMACEUTICALS | -2.4% |
-3.1% |
36.4% |
| SENSEX | -2.8% |
-6.1% |
-11.9% |
You may also like the below Video Courses